STREAMEX CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
STREAMEX CORP. (STEX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $41.32 per share for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2025-11-14
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2025-03-31 was $17.34, a 17.11% decline year-over-year.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was $20.92, a 300.00% increase year-over-year.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2023-03-31 was $5.23, a 2.43% decline year-over-year.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2022-03-31 was $5.36, a 28.82% decline year-over-year.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2022 was $4.54, a 26.66% decline from fiscal 2021.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2021 was $6.19, a 19.27% increase from fiscal 2020.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2020 was $5.19, a 5.81% decline from fiscal 2019.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2019 was $5.51, a 18.75% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | $41.32 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | $48.00 10-Q · filed 2025-08-15 | ||||
| 2025-03-31 | $17.34 10-Q · filed 2025-05-19 | ||||
| 2024-09-30 | $28.97 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | $28.86 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | $20.92 10-Q · filed 2024-05-20 | ||||
| 2023-12-31 | $48.00 10-Q · filed 2025-05-19 | $44.69 10-K · filed 2025-04-15 | |||
| 2023-06-30 | $4.60 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | $5.23 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $4.54 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | $4.69 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $4.93 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | $5.36 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | $6.19 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $6.68 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | $7.23 10-Q · filed 2021-08-11 | ||||
| 2021-03-31 | $7.53 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | $5.19 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $5.23 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | $5.87 10-Q · filed 2020-08-06 | ||||
| 2020-03-31 | $6.49 10-Q · filed 2020-05-11 | ||||
| 2019-12-31 | $5.51 10-K · filed 2021-03-15 | ||||
| 2018-12-31 | $4.64 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $3.90 10-Q · filed 2018-11-02 | ||||
| 2018-06-30 | $1.56 10-Q · filed 2018-07-27 | ||||
| 2018-03-31 | $1.66 10-Q · filed 2018-05-04 | ||||
| 2017-12-31 | $5.43 10-K · filed 2019-03-15 | $2.17 10-K · filed 2018-02-27 | |||
| 2017-09-30 | $2.17 10-Q · filed 2017-11-09 | ||||
| 2016-12-31 | $2.24 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $2.24 10-Q · filed 2016-11-14 | ||||
| 2016-06-30 | $2.50 10-Q · filed 2016-08-12 | ||||
| 2015-12-31 | $0.00 10-K · filed 2017-04-11 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-13 | ||||
| 2015-06-30 | $0.00 10-Q · filed 2015-07-28 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-01 | ||||
| 2014-12-31 | -$2.00 10-K · filed 2016-03-14 | ||||
| 2014-09-30 | $2.00 10-Q · filed 2014-10-17 | ||||
| 2013-12-31 | $0.00 10-K · filed 2015-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |